BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

473 related articles for article (PubMed ID: 31646479)

  • 1. Agonists and Antagonists for Purinergic Receptors.
    Müller CE; Baqi Y; Namasivayam V
    Methods Mol Biol; 2020; 2041():45-64. PubMed ID: 31646479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological profiles of cloned mammalian P2Y-receptor subtypes.
    von Kügelgen I
    Pharmacol Ther; 2006 Jun; 110(3):415-32. PubMed ID: 16257449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purinergic Signaling: Impact of GPCR Structures on Rational Drug Design.
    Salmaso V; Jacobson KA
    ChemMedChem; 2020 Nov; 15(21):1958-1973. PubMed ID: 32803849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pyridoxine cyclic phosphate and its 6-azoaryl derivative selectively potentiate and antagonize activation of P2X1 receptors.
    Jacobson KA; Kim YC; Wildman SS; Mohanram A; Harden TK; Boyer JL; King BF; Burnstock G
    J Med Chem; 1998 Jun; 41(13):2201-6. PubMed ID: 9632352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of cultured dorsal root ganglion neuron P2X receptors.
    Grubb BD; Evans RJ
    Eur J Neurosci; 1999 Jan; 11(1):149-54. PubMed ID: 9987019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Participation of peripheral P2Y1, P2Y6 and P2Y11 receptors in formalin-induced inflammatory pain in rats.
    Barragán-Iglesias P; Mendoza-Garcés L; Pineda-Farias JB; Solano-Olivares V; Rodríguez-Silverio J; Flores-Murrieta FJ; Granados-Soto V; Rocha-González HI
    Pharmacol Biochem Behav; 2015 Jan; 128():23-32. PubMed ID: 25449358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. P2X and P2Y purinergic receptors on human intestinal epithelial carcinoma cells: effects of extracellular nucleotides on apoptosis and cell proliferation.
    Coutinho-Silva R; Stahl L; Cheung KK; de Campos NE; de Oliveira Souza C; Ojcius DM; Burnstock G
    Am J Physiol Gastrointest Liver Physiol; 2005 May; 288(5):G1024-35. PubMed ID: 15662049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Agonists and antagonists for P2 receptors.
    Jacobson KA; Costanzi S; Joshi BV; Besada P; Shin DH; Ko H; Ivanov AA; Mamedova L
    Novartis Found Symp; 2006; 276():58-68; discussion 68-72, 107-12, 275-81. PubMed ID: 16805423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological characterization of P2Y receptor subtypes - an update.
    von Kügelgen I
    Purinergic Signal; 2024 Apr; 20(2):99-108. PubMed ID: 37697211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methanocarba modification of uracil and adenine nucleotides: high potency of Northern ring conformation at P2Y1, P2Y2, P2Y4, and P2Y11 but not P2Y6 receptors.
    Kim HS; Ravi RG; Marquez VE; Maddileti S; Wihlborg AK; Erlinge D; Malmsjö M; Boyer JL; Harden TK; Jacobson KA
    J Med Chem; 2002 Jan; 45(1):208-18. PubMed ID: 11754592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacology and structure of P2Y receptors.
    von Kügelgen I; Hoffmann K
    Neuropharmacology; 2016 May; 104():50-61. PubMed ID: 26519900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. P2 Receptors in Cardiac Myocyte Pathophysiology and Mechanotransduction.
    Woo SH; Trinh TN
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33383710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Action of natural products on p2 receptors: a reinvented era for drug discovery.
    Faria R; Ferreira L; Bezerra R; Frutuoso V; Alves L
    Molecules; 2012 Nov; 17(11):13009-25. PubMed ID: 23117439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purine and purinergic receptors.
    Burnstock G
    Brain Neurosci Adv; 2018; 2():2398212818817494. PubMed ID: 32166165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purinergic receptors in human placenta: evidence for functionally active P2X4, P2X7, P2Y2, and P2Y6.
    Roberts VH; Greenwood SL; Elliott AC; Sibley CP; Waters LH
    Am J Physiol Regul Integr Comp Physiol; 2006 May; 290(5):R1374-86. PubMed ID: 16373435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular pharmacology of P2Y-receptors.
    von Kügelgen I; Wetter A
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Nov; 362(4-5):310-23. PubMed ID: 11111826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective potentiation of homomeric P2X2 ionotropic ATP receptors by a fast non-genomic action of progesterone.
    De Roo M; Boué-Grabot E; Schlichter R
    Neuropharmacology; 2010 Mar; 58(3):569-77. PubMed ID: 20004677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. P2 receptors activated by uracil nucleotides--an update.
    Brunschweiger A; Müller CE
    Curr Med Chem; 2006; 13(3):289-312. PubMed ID: 16475938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P2 purinergic receptors signal to STAT3 in astrocytes: Difference in STAT3 responses to P2Y and P2X receptor activation.
    Washburn KB; Neary JT
    Neuroscience; 2006 Oct; 142(2):411-23. PubMed ID: 16905269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medicinal chemistry of P2 and adenosine receptors: Common scaffolds adapted for multiple targets.
    Jacobson KA; IJzerman AP; Müller CE
    Biochem Pharmacol; 2021 May; 187():114311. PubMed ID: 33130128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.